Glass House Brands (GLAS) Inventory Average (2021 - 2026)
Glass House Brands' (GLAS) quarterly Inventory Average came in at $28.9 million in Q1 2026, up 92.97% year-on-year from $15.0 million in Q1 2025, and up 26.67% on a QoQ basis from $22.8 million in Q4 2025.
Glass House Brands (GLAS) Inventory Average (2021 - 2026) Analysis & Trends
Glass House Brands (GLAS) has 6 years of Inventory Average data on file, last reported at $28.9 million in Q1 2026.
- On a quarterly basis, Inventory Average rose 92.97% year-over-year to $28.9 million in Q1 2026; TTM through Mar 2026 was $28.9 million, a 92.97% increase from a year earlier, with the FY2025 full-year figure at $20.2 million, up 75.29% from the prior year.
- Inventory Average for Q1 2026 stood at $28.9 million, up from $22.8 million in the prior quarter.
- Over the last five years, Inventory Average for GLAS reached as high as $28.9 million in Q1 2026 and fell as low as $7.1 million in Q1 2022.
- Historically, Inventory Average has averaged $14.9 million across 5 years, with a median of $14.8 million in 2023.
- Across the five-year window, Inventory Average dropped 21.77% in 2024 and surged 92.97% in 2026, its largest moves.
- Year by year, Inventory Average stood at $11.8 million in 2022, then retreated by 8.53% to $10.8 million in 2023, then surged by 43.09% to $15.5 million in 2024, then surged by 47.01% to $22.8 million in 2025, then increased by 26.67% to $28.9 million in 2026.
- Per Business Quant data, the three most recent Inventory Average figures were $28.9 million in Q1 2026, $22.8 million in Q4 2025, and $19.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | 1.45 Bn |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 3.18 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 2.51 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 9.02 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 180.70 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 3.96 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 66.75 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 1.73 Bn |
| 10 | Glass House Brands | 873.84 Mn | 845.91 Mn | 10.02 Mn | 28.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.88 Mn |
| Dec 31, 2025 | 22.80 Mn |
| Sep 30, 2025 | 19.52 Mn |
| Jun 30, 2025 | 17.68 Mn |
| Mar 31, 2025 | 14.97 Mn |
| Dec 31, 2024 | 15.51 Mn |
| Sep 30, 2024 | 15.64 Mn |
| Jun 30, 2024 | 12.86 Mn |
| Mar 31, 2024 | 10.03 Mn |
| Dec 31, 2023 | 10.84 Mn |
| Sep 30, 2023 | 14.77 Mn |
| Jun 30, 2023 | 15.69 Mn |
| Mar 31, 2023 | 12.82 Mn |
| Dec 31, 2022 | 11.85 Mn |
| Sep 30, 2022 | 12.50 Mn |
| Jun 30, 2022 | 9.93 Mn |
| Mar 31, 2022 | 7.06 Mn |
| Dec 31, 2021 | 8.94 Mn |
| Sep 30, 2021 | 11.46 Mn |
| Jun 30, 2021 | 10.20 Mn |